JCO Oncology Practice | 2024
Cost-effectiveness of reduced-intensity allogeneic hematopoietic cell transplantation for older patients with high-risk myelodysplastic syndrome: Analysis of BMT CTN 1102.
Saber W, Bansal A, Li L, Scott BL, Sangaralingham LR, Thao V, Roth JA, Steuten LMG, Wright W, Pidala JA, Mishra A, Maziarz RT, Westervelt P, McGuirk JP, Culter C, Nakamura R, Ramsey SD
PubMed
PMID: 38261970
Abstract
Related Articles
CIBMTR Study #: 1102